Other Information.
−Removed: (a) Appointment of Chief Operating Officer
−Removed: On November 4, 2025, the Company promoted Gregg Landes to Chief Operating Officer of the Company.
−Removed: Landes has been with us since September 2016 and, prior to his promotion to Chief Operating Officer, he had served as Senior Vice President, Operations and Strategic Development since October 2019.
−Removed: Landes had previously served in a variety of positions with us, including as our Vice President, Strategic Development and Operational Excellence from May 2018 to October 2019, Vice President, Innovation and Strategic Development from February 2018 to May 2018, Vice President, Operational Excellence from March 2017 to January 2018, and Vice President, Finance and Corporate Development from September 2016 to March 2017.
−Removed: Prior to joining us, Mr.
−Removed: Landes was a principal at the consulting firm, Tetra Tech, Inc., where he focused on Liquified Natural Gas and Environmental Bankruptcy trusts from July 2013 to August 2016.
−Removed: Prior to Tetra Tech, Mr.
−Removed: Landes was employed by Hess Corporation, a large integrated oil and gas company, where he served as Vice President, Business Development for Hess LNG from June 2007 to July 2013.
−Removed: Prior to Hess Corporation, Mr.
−Removed: Landes worked in a broad range of senior financial and business leadership roles for Cabot Corporation, a leading global specialty chemical company.
−Removed: Landes holds a BSBA in Finance from the University of Florida and an MBA from the F.W.
−Removed: Olin Graduate School of Business at Babson College.
−Removed: There is no arrangement or understanding between Mr.
−Removed: Landes and any other person pursuant to which he was selected as Chief Operating Officer of the Company.
−Removed: There are no transactions in which the Company is a participant and in which Mr.
−Removed: Landes has a material interest that are required to be disclosed under Item 404(a) of Regulation S-K.
−Removed: Landes has no family relationship with any directors or executive officers of the Company.
(c) 10b5-1 Trading Plans
−Removed: During the fiscal quarter ended September 30, 2025, the following directors and executive officers adopted a “rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K of the Exchang e Act) (the “Rule 10b5-1 Sales Plan”).
−Removed: • On August 11, 2025 , Donald R.
−Removed: Young , President and Chief Executive Officer of the Company and a director of the Company, adopted a Rule 10b5-1 Sales Plan.
−Removed: The plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to an aggregate of 100,000 shares of our common stock until December 31, 2025 .
−Removed: • On August 12, 2025 , Steven R.
−Removed: Mitchell , a director of the Company, adopted a Rule 10b5-1 Sales Plan.
−Removed: The plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to an aggregate of 57,541 shares of our common stock until November 12, 2026 .
−Removed: Except as disclosed above, none of our directors or executive officers adopted , modified or terminated any contract, instruction
−Removed: or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” as such term is defined in Item 408(a) of Regulation S-K, during the fiscal quarter ended September 30, 2025 .
−Removed: Executive Employment Agreement, effective as of October 1, 2025, by and between the Company and Grant Thoele (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed with the SEC on September 11, 2025).
−Removed: Executive Employment Agreement, effective as of September 22, 2025, by and between the Company and Glenn Deegan.
−Removed: Confidential Separation and Release Agreement, dated October 1, 2025, by and between the Company and Stephanie Pittman.
+Added: None of our directors or executive officers adopted , modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” as such term is defined in Item 408(a) of Regulation S-K, during the fiscal quarter ended March 31, 2026.
Certification of principal executive officer under Section 302(a) of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Cover Page Interactive Data File (embedded within the Inline XBRL document).
−Removed: Management Contract or compensatory plan or arrangement.
+Added: * The certifications attached as Exhibit 32 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Aspen Aerogels, Inc.
+Added: under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ASPEN AEROGELS, INC.
−Removed: November 6, 2025
/s/ Donald R.
1 unchanged sentence
(principal executive officer)
−Removed: November 6, 2025
/s/ Grant Thoele
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.